Pregnancy and postpartum bring significant hormonal and skin changes — melasma, acne, increased facial hair, stretch marks, and volume shifts. Many patients who were actively maintaining their skin or receiving aesthetic treatments want to know what they can continue, what they should pause, and when they can safely resume.
The short answer is that most elective aesthetic injections should be paused during pregnancy, several energy-based treatments and skincare actives should be avoided, and the safety picture broadens considerably after delivery — though some restrictions remain during breastfeeding.
This article is a procedure-by-procedure guide based on published clinical reviews and expert guidance. It is not medical advice. Patients should discuss their specific situation with their obstetrician and their aesthetic provider.
The evidence problem
The central challenge is that randomized controlled trials do not enroll pregnant or breastfeeding patients for cosmetic procedures. The available evidence comes from:
- Retrospective case reports and case series
- Systematic reviews of the published literature (Trivedi et al., 2017; Garg & Mysore, 2022; Lee et al., 2013)
- Pharmacological reasoning based on how treatments are absorbed, distributed, and metabolized
- Manufacturer labeling and FDA pregnancy categories
No aesthetic injectable or energy-based device has been specifically studied in a controlled manner during pregnancy. All recommendations are therefore precautionary — based on biological plausibility rather than direct evidence of safety.
Neuromodulators (Botox, Dysport, Xeomin, Daxxify, Jeuveau, Letybo)
During pregnancy: pause
Botulinum toxin type A is classified as FDA Pregnancy Category C — animal reproduction studies have shown adverse effects, but there are no adequate and well-controlled studies in humans.
The biological argument for safety is that Botox is injected locally into muscle, stays at the injection site, and is unlikely to enter the systemic circulation in meaningful amounts. The molecule (150 kDa) is too large to cross the placental barrier. A 2024 review in the Journal of Cutaneous and Aesthetic Surgery noted that inadvertent exposure during pregnancy has not been associated with fetal adverse effects in case reports, but the data is far too limited to support elective cosmetic use.
All major medical and aesthetic society guidelines recommend against elective cosmetic botulinum toxin use during pregnancy.
During breastfeeding: generally recommended to wait
Botox is not expected to enter breast milk — it stays at the injection site and does not enter the bloodstream in significant quantities. The Royal Hospital for Women's MotherSafe service (Australia) notes that "Botox, if injected properly, should not enter breastmilk. No specific breastfeeding precautions are required."
However, because secretion into breast milk has not been formally studied, most providers recommend waiting until breastfeeding is complete before resuming treatment.
When to resume
Most providers recommend resuming neuromodulator treatment after pregnancy and after breastfeeding is complete. Some providers will treat patients who have stopped breastfeeding but have not yet weaned fully — this is a case-by-case discussion.
Dermal fillers (hyaluronic acid, CaHA, PLLA, PMMA)
During pregnancy: do not use
Dermal fillers are not studied in pregnancy. All major filler manufacturers explicitly state that their products should not be used during pregnancy.
Beyond the lack of safety data, there are practical reasons to avoid filler during pregnancy:
- Hormonal fluctuations cause facial volume changes (fuller cheeks, plumper lips) that would be further altered by filler
- Pregnancy increases blood volume and vascular permeability, which may increase swelling and bruising risk
- The immune system is altered during pregnancy, potentially affecting how the body responds to filler
A 2022 review in the Journal of Cutaneous and Aesthetic Surgery classifies dermal fillers as contraindicated during pregnancy. This applies to all filler types — hyaluronic acid, calcium hydroxylapatite (Radiesse), poly-L-lactic acid (Sculptra), and PMMA (Bellafill).
During breastfeeding: mixed guidance, most recommend waiting
Hyaluronic acid fillers are theoretically low risk during breastfeeding — HA is a naturally occurring molecule, fillers are injected locally, and systemic absorption is negligible. The InfantRisk Center (Texas Tech University) has stated that hyaluronic acid fillers are "your safest, most studied option" for patients who are breastfeeding, noting that fillers "stay in the tissue where they are placed" and "do not transfer into breast milk."
However, other providers and manufacturer labeling recommend waiting. The precautionary approach is to delay all filler treatment until breastfeeding is complete.
Biostimulatory fillers (Sculptra, Radiesse, Bellafill) should be avoided during both pregnancy and breastfeeding due to their longer duration, inflammatory mechanism, and complete lack of reproductive safety data.
Laser and light-based treatments
Laser hair removal during pregnancy: generally considered safe, with caveats
Laser hair removal uses light energy that heats the hair follicle at the skin surface. The laser does not penetrate beyond the dermis and poses no risk to the fetus. A systematic review by Wilkerson et al. (2017) found no reported significant harm to mother or fetus from cutaneous laser treatment during any stage of pregnancy across decades of reported use.
However, some providers choose to defer laser hair removal during the first trimester as a precaution, and pregnancy can increase hair growth (hirsutism) that may resolve postpartum — making treatment during pregnancy potentially unnecessary.
Laser hair removal during breastfeeding: safe
No evidence suggests that laser hair removal affects breast milk or the breastfeeding infant. Treatment can continue during lactation.
Laser resurfacing and vascular treatments during pregnancy: generally deferred
Fractional CO₂, erbium, and vascular lasers are more aggressive than hair removal lasers. While there is no evidence of fetal harm, the associated discomfort, potential need for topical anesthetic, and post-treatment recovery make most providers reluctant to perform elective resurfacing during pregnancy.
The 2017 systematic review by Trivedi et al. concluded that laser therapy during pregnancy has "a high level of safety" but noted that the existing evidence supports medically necessary laser procedures (e.g., treatment of genital warts) rather than elective cosmetic resurfacing.
During breastfeeding: can resume
Laser treatments for the face, including fractional resurfacing, vascular treatments, and pigment correction, are generally considered safe during breastfeeding. Some providers recommend avoiding laser treatment directly over the breast/nipple area during lactation.
Chemical peels
During pregnancy: depends on the agent
- Glycolic acid and lactic acid (AHA): These have small molecular sizes but are used topically at low concentrations. Some providers consider superficial glycolic peels acceptable during pregnancy. The evidence is limited and recommendations are inconsistent.
- Salicylic acid (BHA): Oral salicylates are associated with pregnancy complications. Topical salicylic acid absorption is minimal, but most providers recommend avoiding salicylic acid peels during pregnancy as a precaution.
- TCA (trichloroacetic acid): Avoid. Systemic absorption increases with concentration and depth.
- Jessner's peel and phenol peel: Avoid. Phenol is systemically absorbed and cardiotoxic at high doses.
During breastfeeding: broader options
Superficial to medium-depth peels using glycolic acid, lactic acid, or low-concentration TCA are generally considered safe during breastfeeding. Salicylic acid peels can be resumed.
Microneedling and RF microneedling
During pregnancy: avoid
Microneedling during pregnancy is generally avoided for several reasons:
- It creates controlled micro-injuries to the skin, which triggers an inflammatory and wound-healing response — a process that is altered during pregnancy
- Many microneedling protocols include topical anesthetics or serums (hyaluronic acid, PRP, exosomes, growth factors) that have not been studied in pregnancy
- RF microneedling adds radiofrequency energy, which generates heat in the dermis
During breastfeeding: can resume
Microneedling and RF microneedling can be resumed during breastfeeding, provided the topical products used during the procedure are breastfeeding-safe. This includes most standard hyaluronic acid serums. Products containing retinoids, growth factors, or exosomes should be discussed with the provider.
Skincare actives
Ingredients to avoid during pregnancy
- Retinoids (retinol, tretinoin, adapalene, tazarotene): Oral retinoids (isotretinoin) are absolutely contraindicated — they are potent teratogens. Topical retinoids have much lower systemic absorption, but the FDA and most dermatology guidelines recommend avoiding them during pregnancy due to the theoretical risk.
- Hydroquinone: This skin-lightening agent has high percutaneous absorption (35–45% of applied dose). It should be avoided during both pregnancy and breastfeeding.
- Oral salicylic acid: Avoid for the same reasons as salicylic acid peels.
- Formaldehyde-releasing preservatives: Found in some cosmetics. Best avoided during pregnancy as a precaution.
Generally considered safe during pregnancy
- Vitamin C (L-ascorbic acid): Topical antioxidant, safe during pregnancy. Useful for managing pregnancy-related hyperpigmentation.
- Niacinamide: Safe during pregnancy. Can help with acne and hyperpigmentation.
- Hyaluronic acid: Topical hydration, safe during pregnancy.
- Azelaic acid: Topical, safe during pregnancy. Often recommended for pregnancy-related acne and melasma.
- Zinc oxide and titanium dioxide sunscreens: Physical/mineral sunscreens, safe and strongly recommended. Sun protection is especially important during pregnancy because hormonal changes increase melasma risk.
- Glycolic acid (low concentration): Many providers consider OTC glycolic acid products (≤10%) acceptable during pregnancy.
Body contouring and skin tightening
During pregnancy: not applicable
Body contouring devices (CoolSculpting, Emsculpt Neo) and skin tightening devices (Ultherapy, Thermage, Sofwave) are not performed during pregnancy. There is no data on safety, and the physiological changes of pregnancy (weight gain, fluid retention, hormonal shifts) make results unpredictable.
During breastfeeding: can resume with provider guidance
Most body contouring and skin tightening treatments can be resumed postpartum once the provider determines the patient is medically appropriate. Some providers recommend waiting until the body has stabilized postpartum (typically 3–6 months after delivery) before starting body contouring, as weight and skin laxity continue to change.
Treatment directly over the breasts should be avoided during breastfeeding.
Summary: quick reference
| Treatment | During pregnancy | During breastfeeding |
|---|---|---|
| Botox / neuromodulators | Pause | Generally recommended to wait |
| Hyaluronic acid fillers | Do not use | Low risk; most recommend waiting |
| Biostimulatory fillers (Sculptra, Radiesse) | Do not use | Avoid until breastfeeding complete |
| Laser hair removal | Generally safe; some defer first trimester | Safe |
| Laser resurfacing / vascular | Generally deferred | Can resume |
| Chemical peels (glycolic, lactic) | Possibly safe at low concentrations | Safe |
| Chemical peels (TCA, salicylic, phenol) | Avoid | Resume with provider guidance |
| Microneedling / RF microneedling | Avoid | Can resume |
| Body contouring | Not performed | Can resume postpartum |
| Retinoids (topical) | Avoid | Resume with provider guidance |
| Hydroquinone | Avoid | Avoid |
| Vitamin C, niacinamide, HA, azelaic acid | Safe | Safe |
| Mineral sunscreen | Safe and recommended | Safe |
Sources
- Trivedi MK, Kroumpouzos G, Murase JE. "A review of the safety of cosmetic procedures during pregnancy and lactation." International Journal of Women's Dermatology. 2017;3(1):6-10. doi:10.1016/j.ijwd.2016.12.003. https://pmc.ncbi.nlm.nih.gov/articles/PMC5418954
- Garg AM, Mysore V. "Dermatologic and Cosmetic Procedures in Pregnancy." Journal of Cutaneous and Aesthetic Surgery. 2022;15(2):108-117. https://jcasonline.com/dermatologic-and-cosmetic-procedures-in-pregnancy
- Wilkerson EC, Van Acker MM, Bloom BS, Goldberg DJ. "Utilization of Laser Therapy During Pregnancy: A Systematic Review of the Maternal and Fetal Effects Reported From 1960 to 2017." Dermatologic Surgery. 2017;43(9):1151-1160.
- Lee KC, Korgavkar K, Dufresne RG Jr, Higgins HW II. "Safety of cosmetic dermatologic procedures during pregnancy." Dermatologic Surgery. 2013;39(11):1573-1586.
- U.S. FDA. "BOTOX® Cosmetic (onabotulinumtoxinA) Prescribing Information." https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/103000s5316s5319s5323s5326s5331lbl.pdf
- MotherToBaby. "Maintaining Your Glow: Navigating Cosmetic Procedures While Pregnant or Breastfeeding." https://mothertobaby.org/baby-blog/maintaining-your-glow-navigating-cosmetic-procedures-while-pregnant-or-breastfeeding
- Royal Hospital for Women, Sydney. "Skin Care, Hair Care and Cosmetic Treatments in Pregnancy and Breastfeeding." MotherSafe Information Leaflet. Updated March 2021. https://www.seslhd.health.nsw.gov.au
- InfantRisk Center, Texas Tech University. "Are Dermal Fillers Safe While Breastfeeding?" https://www.infantrisk.com/content/are-dermal-fillers-safe-while-breastfeeding
- NCT (National Childbirth Trust). "Which beauty and wellbeing treatments are safe during pregnancy and breastfeeding?" https://www.nct.org.uk/information/pregnancy/wellbeing-and-lifestyle-pregnancy
